In addition, MERTK expression was increased when NSCLC cell lines were treated with AXL inhibitor or AXL expression was inhibited using siRNA and dual inhibition of AXL and MERTK reduced cell expansion in vitro and tumor growth in vivo [78]. The gene discussed is MERTK; the disease is non-small cell lung carcinoma.